(19)
(11) EP 0 776 335 A1

(12)

(43) Date of publication:
04.06.1997 Bulletin 1997/23

(21) Application number: 95930868.0

(22) Date of filing: 18.08.1995
(51) International Patent Classification (IPC): 
A01K 67/ 027( . )
C07K 7/ 64( . )
C07K 14/ 725( . )
C12N 5/ 10( . )
C12N 15/ 63( . )
A61K 48/ 00( . )
C07K 14/ 715( . )
C07K 19/ 00( . )
C12N 15/ 09( . )
C12P 17/ 18( . )
(86) International application number:
PCT/US1995/010591
(87) International publication number:
WO 1996/006111 (29.02.1996 Gazette 1996/10)
(84) Designated Contracting States:
AT CH DE FR GB LI SE

(30) Priority: 18.08.1994 US 19940292595
18.08.1994 US 19940292596
18.08.1994 US 19940292597

(71) Applicant: ARIAD GENE THERAPEUTICS, INC.
Cambridge, MA 02139 (US)

(72) Inventors:
  • BRUGGE, Joan, S.
    Concord, MA 01742 (US)
  • CRABTREE, Gerald, R.
    Woodside, CA 94062 (US)

(74) Representative: Marchant, James Ian, et al 
Elkington and Fife, Prospect House, 8 Pembroke Road
Sevenoaks, Kent TN13 1XR
Sevenoaks, Kent TN13 1XR (GB)

   


(54) REGULATABLE ELIMINATION OF GENE EXPRESSION, GENE PRODUCT FUNCTION AND ENGINEERED HOST CELLS